CS logo
small CS logo
MBCCOP - University of New Mexico HSC

Albuquerque, New Mexico, United States
Skin care clinic in Albuquerque, New Mexico
1021 Medical Arts Ave NE, Albuquerque, NM 87102

About MBCCOP - University of New Mexico HSC


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
SWOG Cancer Research Network
53
University of New Mexico
30
Eastern Cooperative Oncology Group
11
Alliance for Clinical Trials in Oncology
5
Mannkind Corporation
4
Novartis
4
Duke University
3
Glaxo Wellcome
3
Gynecologic Oncology Group
3
IDeA States Pediatric Clinical Trials Network
3
NYU Langone Health
3
Total Rows: 58

Clinical Trials at MBCCOP - University of New Mexico HSC


During the past decade, MBCCOP - University of New Mexico HSC conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 21 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 9 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1155337755131344442233115511111144Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS
Completed
180
Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARC
Completed
A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC
Completed
The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)
Completed
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
Completed
750
Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
Completed
5,000
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
1993-12-01
Completed
216
Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
1994-07-01
2018-05-21
Completed
299

Rows per page:

1–100 of 178

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "MBCCOP - University of New Mexico HSC" #1 sponsor was "SWOG Cancer Research Network" with 53 trials, followed by "University of New Mexico" with 30 trials sponsored, "Eastern Cooperative Oncology Group" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored and "Mannkind Corporation" with 5 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 58 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "MBCCOP - University of New Mexico HSC" #1 collaborator was "National Cancer Institute (NCI)" with 80 trials as a collaborator, "SWOG Cancer Research Network" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 4 trials as a collaborator. Other collaborators include 94 different institutions and companies that were collaborators in the rest 75 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSWOG Cancer ResearchNetwork: 53SWOG Cancer ResearchNetwork: 53University of New Mexico: 30University of New Mexico: 30Eastern CooperativeOncology Group: 11Eastern CooperativeOncology Group: 11Alliance for ClinicalTrials in Oncology: 5Alliance for ClinicalTrials in Oncology: 5Mannkind Corporation: 4Mannkind Corporation: 4Novartis: 4Novartis: 4Duke University: 3Duke University: 3Glaxo Wellcome: 3Glaxo Wellcome: 3Gynecologic Oncology Group: 3Gynecologic Oncology Group: 3IDeA States PediatricClinical Trials Network:3IDeA States PediatricClinical Trials Network:3

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 80National CancerInstitute (NCI): 80SWOG Cancer ResearchNetwork: 12SWOG Cancer ResearchNetwork: 12Eastern CooperativeOncology Group: 11Eastern CooperativeOncology Group: 11Cancer and LeukemiaGroup B: 10Cancer and LeukemiaGroup B: 10Eunice Kennedy ShriverNational Institute ofChild Health and HumanDevelopment (NICHD): 4Eunice Kennedy ShriverNational Institute ofChild Health and HumanDevelopment (NICHD): 4National Heart, Lung,and Blood Institute(NHLBI): 4National Heart, Lung,and Blood Institute(NHLBI): 4National Institutes ofHealth (NIH): 4National Institutes ofHealth (NIH): 4The Emmes Company, LLC: 4The Emmes Company, LLC: 4University of New Mexico: 4University of New Mexico: 4National Center forAdvancing TranslationalSciences (NCATS): 3National Center forAdvancing TranslationalSciences (NCATS): 3

Clinical Trials Conditions at MBCCOP - University of New Mexico HSC


According to Clinical.Site data, the most researched conditions in "MBCCOP - University of New Mexico HSC" are "Lung Cancer" (12 trials), "Breast Cancer" (9 trials), "Leukemia" (8 trials), "Lymphoma" (7 trials) and "Colorectal Cancer" (6 trials). Many other conditions were trialed in "MBCCOP - University of New Mexico HSC" in a lesser frequency.

Clinical Trials Intervention Types at MBCCOP - University of New Mexico HSC


Most popular intervention types in "MBCCOP - University of New Mexico HSC" are "Drug" (137 trials), "Biological" (23 trials), "Radiation" (19 trials), "Procedure" (18 trials) and "Other" (12 trials). Other intervention types were less common.
The name of intervention was led by "cisplatin" (15 trials), "radiation therapy" (15 trials), "Placebo" (13 trials), "cyclophosphamide" (10 trials) and "fluorouracil" (10 trials). Other intervention names were less common.

Clinical Trials Genders at MBCCOP - University of New Mexico HSC


The vast majority of trials in "MBCCOP - University of New Mexico HSC" are 145 trials for "All" genders, 27 trials for "Female" genders and 6 trials for "Male" genders.

Clinical Trials Status at MBCCOP - University of New Mexico HSC


Currently, there are NaN active trials in "MBCCOP - University of New Mexico HSC". undefined are not yet recruiting, 18 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 124 completed trials in MBCCOP - University of New Mexico HSC, undefined suspended trials, and 21 terminated clinical trials to date.
Out of the total trials that were conducted in MBCCOP - University of New Mexico HSC, 3 "Phase 1" clinical trials were conducted, 60 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 30 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 62Phase 3: 62Phase 2: 60Phase 2: 60Not Applicable: 30Not Applicable: 30Phase 4: 7Phase 4: 7Early Phase 1: 3Early Phase 1: 3Phase 1: 3Phase 1: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 124Completed: 124Terminated: 21Terminated: 21Recruiting: 18Recruiting: 18Unknown status: 6Unknown status: 6Withdrawn: 5Withdrawn: 5Active, not recruiting: 3Active, not recruiting: 3No longer available: 1No longer available: 1